Does aliskiren protect the kidney following ischemia reperfusion injury

Physiological Research

Volumn 62, Issue 6, 2013, Pages 681-690

  Hammad, Fayez T ^a   Al Salam, S ^a   Lubbad, L ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Aliskiren; Ischemia reperfusion injury; Renal function

Indexed keywords

ALISKIREN; AMIDE; FUMARIC ACID DERIVATIVE; RENIN; URINARY TRACT AGENT;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY CIRCULATION; KIDNEY DISEASE; MALE; PATHOPHYSIOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; TREATMENT OUTCOME; WISTAR RAT;

AMIDES; ANIMALS; FUMARATES; GLOMERULAR FILTRATION RATE; KIDNEY; KIDNEY DISEASES; MALE; RATS; RATS, WISTAR; RENAL AGENTS; RENAL CIRCULATION; RENIN; RENIN-ANGIOTENSIN SYSTEM; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 84891645230     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. AXELSEN RA, CARTWRIGHT VE: Renal function, cortical blood flow and morphometry in ischaemic acute renal failure in the rat. Pathology 11: 629-640, 1979.
2. BRADY H, BRENNER B, LIEBERTHAL W: Acute renal failure. In: The Kidney. B. M. BRENNER (ed), W. B. Saunders Company, Philadelphia, 1996, 1201-1252.
3. CHOI DE, JEONG JY, LIM BJ, CHANG YK, NA KR, SHIN YT, LEE KW: Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice. J Urol 186: 694-701, 2011.
4. CORDERO P, FISHER ND, MOORE TJ, GLEASON R, WILLIAMS GH, HOLLENBERG NK: Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans. Hypertension 17: 510-516, 1991.
5. EDWARDS RM: Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 244: F526-F534, 1983.
6. FAVREAU F, THUILLIER R, CAU J, MILIN S, MANGUY E, MAUCO G, ZHU X, LERMAN LO, HAUET T: Antithrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant 10: 30-39, 2010.
7. FISHER ND, ALLAN D, KIFOR I, GABOURY CL, WILLIAMS GH, MOORE TJ, HOLLENBERG NK: Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans. Hypertension 23: 44-51, 1994.
8. FOUAD AA, QURESHI HA, AL-SULTAN AI, YACOUBI MT, AL-MELHIM WN: Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury. Pharmacology 85: 158-167, 2010.
9. HABIBEY R, AJAMI M, HESAMI A, PAZOKI-TOROUDI H: The mechanism of preventive effect of captopril on renal ischemia reperfusion injury is independent of ATP dependent potassium channels. Iran Biomed J 12: 241-245, 2008.
10. HALL JE, GUYTON AC, COWLEY AW Jr: Dissociation of renal blood flow and filtration rate autoregulation by renin depletion. Am J Physiol 232: F215-F221, 1977a.
11. HALL JE, GUYTON AC, JACKSON TE, COLEMAN TG, LOHMEIER TE, TRIPPODO NC: Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 233: F366-F372, 1977b.
12. HAMMAD FT, WHEATLEY AM, DAVIS G: Long-term renal effects of unilateral ureteral obstruction and the role of endothelin. Kidney Int 58: 242-250, 2000.
13. HAMMAD FT, WHEATLEY AM, DAVIS G: Role of endothelin ET(A) receptor antagonism in the post-transplant renal response to angiotensin II in the rat. Exp Physiol 86: 365-372, 2001.
14. HAMMAD FT, AL-SALAM S, LUBBAD L: Curcumin provides incomplete protection of the kidney in ischemia reperfusion injury. Physiol Res 61: 503-511, 2012.
15. JOHNSTON CI, MILLAR JA, MCGRATH BP, MATTHEWS PG: Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension. Lancet 314: 493-496, 1979.
16. JONES MR, SEALEY JE, LARAGH JH: Effects of angiotensin receptor blockers on ambulatory plasma renin activity in healthy, normal subjects during unrestricted sodium intake. Am J Hypertens 20: 907-916, 2007.
17. KIEW LV, MUNAVVAR AS, LAW CH, AZIZAN AN, NAZARINA AR, SIDIK K, JOHNS EJ: Effect of antisense oligodeoxynucleotides for ICAM-1 on renal ischaemia-reperfusion injury in the anaesthetised rat. J Physiol 557: 981-989, 2004.
18. KIRKBY K, BAYLIS C, AGARWAL A, CROKER B, ARCHER L, ADIN C: Intravenous bilirubin provides incomplete protection against renal ischemia-reperfusion injury in vivo. Am J Physiol 292: F888-F894, 2007.
19. KONTOGIANNIS J, BURNS KD: Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol 274: F79-F90, 1998.
20. MACDOUGALL ML, WIEGMANN TB: Excretion of para-aminohippurate in the isolated perfused rat kidney: net secretion and net reabsorption. J Physiol 397: 459-469, 1988.
21. MISHRA J, MA Q, PRADA A, MITSNEFES M, ZAHEDI K, YANG J, BARASCH J, DEVARAJAN P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534-2543, 2003.
22. MOHAN IK, KHAN M, SHOBHA JC, NAIDU MU, PRAYAG A, KUPPUSAMY P, KUTALA VK: Protection against cisplatin-induced nephrotoxicity by Spirulina in rats. Cancer Chemother Pharmacol 58: 802-808, 2006.
23. MOLINAS SM, CORTES-GONZALEZ C, GONZALEZ-BOBADILLA Y, MONASTEROLO LA, CRUZ C, ELIAS MM, BOBADILLA NA, TRUMPER L: Effects of losartan pretreatment in an experimental model of ischemic acute kidney injury. Nephron Exp Nephrol 112: e10-e19, 2009.
24. PARIKH CR, LU JC, COCA SG, DEVARAJAN P: Tubular proteinuria in acute kidney injury: a critical evaluation of current status and future promise. Ann Clin Biochem 47: 301-312, 2010.
25. PECHMAN KR, DE MIGUEL C, LUND H, LEONARD EC, BASILE DP, MATTSON DL: Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension. Am J Physiol 297: R1358-R1363, 2009.
26. RUBINSTEIN I, ABASSI Z, MILMAN F, OVCHARENKO E, COLEMAN R, WINAVER J, BETTER OS: Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney. Nephrol Dial Transplant 24: 428-436, 2009.
27. RUSAI K, SCHMADERER C, HERMANS JJ, LUTZ J, HEEMANN U, BAUMANN M: Direct renin inhibition in a rat model of chronic allograft injury. Transplantation 92: 999-1004, 2011.
28. SABBATINI M, UCCELLO F, SERIO V, TRONCONE G, VARONE V, ANDREUCCI M, FAGA T, PISANI A: Effects of mycophenolate mofetil on acute ischaemia-reperfusion injury in rats and its consequences in the long term. Nephrol Dial Transplant 25: 1443-1450, 2010.
29. SINGH VP, LE B, KHODE R, BAKER KM, KUMAR R: Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 57: 3297-3306, 2008.
30. SUN CY, CHERNG WJ, JIAN HZ, HSU HH, WU IW, HSU HJ, WU MS: Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury - beyond the direct renin inhibition. Hypertens Res 35: 304-311, 2012.
31. TAIN YL, HSU CN, LIN CY, HUANG LT, LAU YT: Aliskiren prevents hypertension and reduces asymmetric dimethylarginine in young spontaneously hypertensive rats. Eur J Pharmacol 670: 561-565, 2011.
32. TANNER GA, ISENBERG MT: Secretion of p-aminohippurate by rat kidney proximal tubules. Am J Physiol 219: 889- 892, 1970.
33. WEIGHT SC, BELL PR, NICHOLSON ML: Renal ischaemia-reperfusion injury. Br J Surg 83: 162-170, 1996.
34. WHALEY-CONNELL A, NISTALA R, HABIBI J, HAYDEN MR, SCHNEIDER RI, JOHNSON MS, TILMON R, REHMER N, FERRARIO CM, SOWERS JR: Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat. Am J Physiol 298: F655-F661, 2010.
35. WOOD JM, STANTON JL, HOFBAUER KG: Inhibitors of renin as potential therapeutic agents. J Enzyme Inhib 1: 169-185, 1987.
36. WU WP, CHANG CH, CHIU YT, KU CL, WEN MC, SHU KH, WU MJ: A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren. Am J Physiol 299: F929- F941, 2010.
37. ZHAO S, FERNALD RD: Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 12: 1047-1064, 2005.